Urgent Care: Current hours are 7 days a week, 8 AM to midnight all days except Wednesdays (8 AM-8 PM). Call 413-614-0039 for an appointment.

Clinical Trials

A researcher wears protective gear and purple latex gloves while drawing a blood sample into a syringe

Finding better treatments for dogs and cats depends on clinical trials.

At Integrity Veterinary Center, we’re dedicated to improving care for pets by taking part in these studies, which test new medicines and treatment plans.

Your pet’s safety is always our top priority. Every clinical trial we offer has been carefully reviewed to make sure it’s safe before we offer it for your pet.

Individual Clinical Trial Descriptions

Trials currently enrolling:

Investigating a New Drug for Canine Chronic Enteropathy

Integrity Veterinary Center is partnering with Cornell University’s College of Veterinary Medicine on a clinical trial testing a new drug, GLS-1027, for dogs with chronic enteropathy (inflammatory bowel disease) that has not improved with diet changes or antibiotics. The study, led by Cornell’s Dr. Jennifer Prieto, evaluates whether adding low-dose GLS-1027 to a reduced steroid regimen can control inflammation as effectively as standard steroid therapy alone, while potentially reducing side effects. Dogs treated at Integrity Veterinary Center who meet strict diagnostic criteria and have biopsy-confirmed IBD may qualify. Participants receive the study medication or placebo at no cost, free lab work at set intervals, and a 10% discount on study-related visits, while owners agree to give medications, track symptoms, and attend two follow-up appointments over the 28-day trial.

Clinic trail graphic for Investigating a New Drug for Canine Chronic Enteropathy

Exploring the Genetics of Diabetes in Cats

Integrity Veterinary Center is partnering with Cornell University’s College of Veterinary Medicine to support a research study investigating the genetic factors that contribute to diabetes mellitus in domestic cats. Led by Dr. Rory Todhunter with co-investigator Dr. Jessica Hayward and collaborator Dr. John Loftus, the project aims to identify genetic variations that may increase a cat’s risk of developing diabetes. Integrity Veterinary Center is helping by collecting and submitting samples from eligible cats, which will provide critical data for understanding the disease and guiding future prevention and treatment strategies. This study requires taking a small amount of blood to be sent to Cornell for genetic testing.

Upcoming Trials

Evaluating a CBD Oil Blend in Dogs with Kidney Disease

This clinical trial is evaluating whether a hemp-derived supplement can help dogs with moderate chronic kidney disease. Dogs with stable Stage II or III kidney failure will receive either twice-daily CBDA/CBGA soft gels or a placebo, in addition to their usual kidney treatments. Over six months, veterinarians will monitor kidney function with blood and urine tests, blood pressure checks, and physical exams, while owners complete quality-of-life surveys. Eligible dogs must have been on a kidney-supportive diet and stable medications for at least two months and cannot have serious additional illnesses such as diabetes, liver disease, or uncontrolled heart problems. Study visits are scheduled at 1, 3, and 6 months, and all study-related lab work and supplements are provided at no cost.